Agilent Technologies, Inc. $A Position Lifted by Generation Investment Management LLP

Generation Investment Management LLP lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 15.9% during the second quarter, HoldingsChannel.com reports. The fund owned 5,775,860 shares of the medical research company’s stock after purchasing an additional 792,304 shares during the quarter. Agilent Technologies makes up 4.3% of Generation Investment Management LLP’s holdings, making the stock its 7th largest position. Generation Investment Management LLP’s holdings in Agilent Technologies were worth $681,609,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Alps Advisors Inc. boosted its holdings in Agilent Technologies by 29.5% during the first quarter. Alps Advisors Inc. now owns 13,358 shares of the medical research company’s stock worth $1,563,000 after buying an additional 3,040 shares in the last quarter. TrueMark Investments LLC acquired a new stake in shares of Agilent Technologies in the 2nd quarter worth approximately $1,999,000. Fenimore Asset Management Inc increased its stake in Agilent Technologies by 2.7% in the 2nd quarter. Fenimore Asset Management Inc now owns 180,880 shares of the medical research company’s stock valued at $21,346,000 after purchasing an additional 4,823 shares in the last quarter. Asset Management One Co. Ltd. boosted its position in Agilent Technologies by 3.4% during the second quarter. Asset Management One Co. Ltd. now owns 124,577 shares of the medical research company’s stock worth $14,701,000 after purchasing an additional 4,152 shares in the last quarter. Finally, Brighton Jones LLC grew its holdings in Agilent Technologies by 89.5% in the second quarter. Brighton Jones LLC now owns 9,068 shares of the medical research company’s stock valued at $1,070,000 after purchasing an additional 4,284 shares during the last quarter. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently commented on A. Rothschild & Co Redburn initiated coverage on shares of Agilent Technologies in a research note on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price objective on the stock. Barclays upped their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a report on Thursday, October 2nd. Robert W. Baird raised their price objective on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research note on Thursday, August 28th. TD Cowen lifted their price objective on Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Stock Performance

NYSE:A opened at $146.69 on Monday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The firm has a market cap of $41.59 billion, a PE ratio of 34.43, a P/E/G ratio of 4.67 and a beta of 1.29. The firm has a 50 day simple moving average of $135.48 and a 200-day simple moving average of $122.56. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.37. The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. Agilent Technologies’s revenue was up 10.1% compared to the same quarter last year. During the same quarter last year, the business earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th were given a $0.248 dividend. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is currently 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.